UBS O'Connor’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,287,987
Closed -$122M 330
2018
Q3
$122M Sell
1,287,987
-108,051
-8% -$9.21M 2.81% 6
2018
Q2
$108M Buy
1,396,038
+1,296,038
+1,296% +$97.2M 2.16% 8
2018
Q1
$6.91M Buy
+100,000
New +$7.63M 0.13% 80
2017
Q4
Sell
-306,000
Closed -$19.4M 422
2017
Q3
$19.4M Sell
306,000
-172,295
-36% -$10.7M 0.28% 79
2017
Q2
$30.5M Sell
478,295
-295,676
-38% -$18.6M 0.5% 46
2017
Q1
$51M Buy
773,971
+245,927
+47% +$16.9M 0.86% 24
2016
Q4
$36.3M Sell
528,044
-221,956
-30% -$15.9M 0.7% 31
2016
Q3
$52.9M Buy
750,000
+153,519
+26% +$11.5M 0.79% 26
2016
Q2
$45.2M Buy
596,481
+196,756
+49% +$14.5M 0.98% 25
2016
Q1
$27.5M Buy
+399,725
New +$28.7M 0.5% 56
2015
Q3
Sell
-5,480
Closed -$487K 809
2015
Q2
$487K Buy
5,480
+2,148
+64% +$188K 0.01% 572
2015
Q1
$289K Buy
+3,332
New +$279K 0.01% 622
2013
Q3
Sell
-67,000
Closed -$4.13M 616
2013
Q2
$4.13M Buy
+67,000
New +$4.03M 0.08% 259

Other funds holding ESRX

UBS O'Connor's ESRX Position: Q4 2018 in Review

UBS O'Connor sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 1,287,987 shares — an estimated $122M sold.

UBS O'Connor first reported a position in ESRX in Q2 2013 and held it in 13 quarters. The position peaked at $122M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • UBS O'Connor reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • UBS O'Connor sold 1,287,987 Express Scripts Holding Company shares in Q4 2018, an estimated $122M.
  • UBS O'Connor first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 13 quarters.
  • UBS O'Connor's Express Scripts Holding Company position peaked at $122M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on UBS O'Connor's 13F filing for Q4 2018, filed 15 Feb 2019.